Arrangement, and are you guaranteeing what is the price of the drug when are you saying you are only going to get paid x if you reach a cure level or certain level of adherence. Theres some interference there, and its used as an excuse for those types of arrangement or getting out of those arrangements by pharmaceutical companies. The other is the fda approves the drug if it works. And they dont necessarily approve it saying whether it works better than things that have previously been approved or whether it doesnt work better than thing previously approved. And that can create some friction when it comes to dealing with providers who seem to want to gravitate toward the newest and the latest, even if it really doesnt turn out to work any better than some of the alternatives that have come down the pike before. So whats the solution there . More as we heard on the earlier panel, more effectiveness, information and data . I think the comparative effectiveness would really help. Then you
Providing low income service. Sort of almost to make it politically good, not just politically acceptable, politically good for a company to price discriminate. I wasnt sure where you were headed with that. I cant think of what it is right now. But if they were to take samples of fingerprints that are on some of those voluntary agreements, you might find fingerprints somewhere. Thats good. I think thats great. The programs are there. Just one thing, back to yesterdays conversation. He said the one thing about the act is it allowed competition to enter. What the competition did, is before the telecomact, the prices that we had didnt make a whole lot of sense. All kinds of different cross subsidies. 25 cents a minute long distance. And what the competition did is forced all those prices to get rationalized. The High Cost Fund kind of impedes that whole process. One thing, theres really i think the benefits in terms of incentives for investment and those other things in the high cost area
To have an abortion is protected under the 14th amendment right to privacy established by the Previous Supreme Court case connecticut v. Griswold. The court ruled, however, that this right is not absolutely and that states can restrict an abortion based on the viability of the fetus. Join us as we examine the case, hear from the justice who wrote the opinion, and explore the impact of roe v. Wade both in its time and since the 1973 decision. Thats coming up tonight starting at 9 00 eastern on cspan and here on cspan3. And following that, American History tv in primetime looks at russian spies including the trial of kgb spy rudolph abel. Sex and kgb spies in the 1970s, espionage in the Manhattan Project and soviet spy couples and the atomic bomb. And thats tonight starting at 10 30 eastern here on cspan3. Well, coming up next, a recent forum hosted by the department of health and Human Services looking into pharmaceutical innovation and drug affordability. In this panel, Health Industry
And coming up, more on the recent health and Human Services forum on pharmaceutical innovation and drug costs. Up next, senators from medicare and medicaid acting administrator andy slavit and purchasing strategies for the pharmaceutical industries. This includes manufacturers, employers, consumers, Health Insurance providers and government officials. Once again, if you will all take your seats well get started on the final panel of the day. Where as promised, well devote our discussion to outcomes based purchasing, what is the potential for those, what are the obstacles and how do we get to better value and better accessibility for patients as soon as possible through these and other mechanisms. Let me introduce our panelists now. You have been introduced to at least this gentleman there, dan durham, Senior Vice President of ahib, thats americas Health Insurance plans. And ken frazier is with us, the president and chief executive officer of merck and company. One of the premier pharma
For them to look at provider directories, the coverage that was talked about and tax season coming up one of the things that will be coming into effect is the shared responsibility fee. Thank you again. Okay, thanks very much, meena. Well turn to dan durham from ahip. Well, good afternoon, thank you, ed and sara. I look forward to talking about where we are in terms of results and expectations and hope to have a lot of good questions and discussion among the Panel Members today. I will focus on health plans top priority, delivering value to consumers. American families want value for the money that they spend on their premium dollars. They want affordable quality coverage and they want choice. The bronze, the pratt numb, tailored networks to prodder provider networks. Health plans are delivering what Consumers Want in a very competitive market. Theyre delivering affordability, value, and choices that meet consumers needs. Health plans are delivering value by negotiating the best price